Matrix metalloproteinase 2 is involved in the regulation of the antimicrobial peptide parasin I production in catfish skin mucosa  by Cho, Ju Hyun et al.
Matrix metalloproteinase 2 is involved in the regulation of
the antimicrobial peptide parasin I production in cat¢sh skin mucosa
Ju Hyun Choa, In Yup Parka, Mi Sun Kimb, Sun Chang Kima;
aDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, 373-1 Kusong-dong Yusong-gu, Taejon 305-701,
South Korea
bBiomass Team, Korea Institute of Energy Research, Taejon 305-343, South Korea
Received 13 September 2002; revised 1 October 2002; accepted 10 October 2002
First published online 22 October 2002
Edited by Stuart Ferguson
Abstract A 19-residue antimicrobial peptide parasin I is gen-
erated from histone H2A in the skin mucus of cat¢sh by the
action of cathepsin D activated by a procathepsin D-processing
enzyme induced upon epidermal injury. Here we report the iso-
lation and characterization of the procathepsin D-processing
enzyme in the mucus of wounded cat¢sh. Sequence analysis of
the cDNA identi¢ed the puri¢ed procathepsin D-processing en-
zyme as matrix metalloproteinase 2 (MMP 2). By acting as a
procathepsin D convertase upon epidermal injury, MMP 2 is
involved in the regulation of parasin I production in cat¢sh skin
mucosa.
- 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Fish are in intimate contact with a rich microbial £ora and
are presumed to use their innate immune system as the ¢rst
line of defense against microbial invasion [1]. Many antimi-
crobial peptides have been isolated from a multitude of ani-
mals, microorganisms and plant species [2], including ¢sh
[3^6], and are recognized as important components of the
innate immunity [7]. These peptides exhibit potent antimicro-
bial activities against a broad range of microorganisms, in-
cluding bacteria, protozoa, fungi and viruses [8]. They can
function intracellularly, as in circulating leukocytes, or in
the external environment after release by secretory cells and
other granulated epithelia [9]. Most of the antimicrobial pep-
tides are made as gene-encoded preproproteins and are pro-
cessed by de¢ned pathways to their active peptide forms [10].
However, an increasing number of antimicrobial peptides are
found to be derived by proteolysis from larger proteins with
other known functions such as lactoferrin [11], ribosomal pro-
tein L1 [12] and histone H2A [13,14].
Recently, a potent 19-residue linear antimicrobial peptide
named parasin I was isolated from the skin mucus of
wounded cat¢sh [4]. The amino acid sequence of parasin I
(KGRGKQGGKVRAKAKTRSS) is identical in 17 of the
19 residues to the N-terminal region of histone H2A from
calf thymus [15]. In a previous study, we demonstrated that
parasin I is generated from unacetylated histone H2A by the
action of cathepsin D; cathepsin D is found to exist in the
mucus as an inactive procathepsin D and to be activated to
mature cathepsin D by an extracellular enzymatic process
induced upon epidermal injury [14]. However, little is known
about the activation of secreted procathepsin D by extracel-
lular proteases except that the procathepsin D-processing en-
zyme induced in the mucus of wounded cat¢sh is a metal-
loprotease [14]. The characterization of the procathepsin
D-processing enzyme would greatly aid in the understanding
of the regulation of parasin I production. In this study, we
identi¢ed and characterized the procathepsin D-processing en-
zyme in the mucus of wounded cat¢sh.
2. Materials and methods
2.1. Materials
pET-16b and Escherichia coli BL21(DE3) were obtained from No-
vagen (Madison, WI, USA). Restriction enzymes and modi¢cation
enzymes for DNA manipulation were from New England Biolabs
(Beverly, MA, USA). Calf thymus histone H2A, leupeptin, pepstatin
A, E-64, ethylenediamine tetraacetic acid (EDTA) and o-phenanthro-
line were purchased from Roche (Mannheim, Germany). Phenylmeth-
ylsulfonyl £uoride (PMSF), pepstatin A-agarose and isopropyl L-D-
thiogalactopyranoside (IPTG) were from Sigma (St. Louis, MO,
USA). All other reagents used in this study were of analytical grade.
2.2. Expression and puri¢cation of recombinant procathepsin D
Cat¢sh procathepsin D gene was polymerase chain reaction (PCR)-
ampli¢ed from the cDNA clone [14] with the upstream primer 5P-
CCGCTCGAGCTGGTTCGGATTCCTC-3P and the downstream
primer 5P-CGGGATCCCTAAATTGCTTTAGCC-3P. The 1021-bp
PCR fragment was digested with XhoI and BamHI (restriction sites
underlined in the primers) and then subcloned into pET-16b digested
with the same restriction enzymes. The resultant vector was named
pET-proCAD and used to transform E. coli BL21(DE3). The result-
ing transformants were cultured in 1.5 l of Luria^Bertani (LB) me-
dium containing ampicillin (50 Wg/ml) at 37‡C. When the absorbance
at 600 nm reached 0.6, IPTG was added to a ¢nal concentration of
1 mM. 3 h after induction, cells were harvested by centrifugation at
6000Ug for 10 min at 4‡C and resuspended in bu¡er A (20 mM Tris^
HCl, pH 7.9, 0.5 M NaCl and 5 mM imidazole). After lysis of cells by
sonication, inclusion bodies were recovered by centrifugation at
13 000Ug for 30 min at 4‡C. The inclusion bodies were denatured
and solubilized in bu¡er A containing 6 M urea (bu¡er B). The sam-
ple was then centrifuged and the supernatant was loaded onto a Ni2þ
a⁄nity column (HisWBind resin, Novagen) equilibrated with the same
bu¡er. After washing out the unbound proteins with bu¡er B con-
taining 20 mM imidazole, the procathepsin D was eluted from the
column with bu¡er B containing 1 M imidazole and dialyzed exten-
sively against bu¡er A. The histidine-tag of the procathepsin D was
cleaved by incubating with factor Xa (New England Biolabs) at room
temperature for 8 h and then the cleavage products were reapplied to
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the Ni2þ a⁄nity column equilibrated with bu¡er A. The recombinant
procathepsin D in the £ow-through fraction was collected and the
purity of recombinant procathepsin D was assessed by 10% sodium
dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE).
2.3. Assay of procathepsin D-processing enzyme activity
Mucus extracts of wounded cat¢sh were prepared as described by
Cho et al. [14]. The mucus extracts were acidi¢ed to pH 3.5 and
applied to a pepstatin A a⁄nity column, which was equilibrated
with 50 mM sodium acetate (pH 3.5) at 4‡C, to remove endogenous
active cathepsin D by binding to the column. The pepstatin A £ow-
through fraction, in which endogenous active cathepsin D was elim-
inated, was then concentrated and desalted by using a Centricon mi-
croconcentrator (Amicon, Beverly, MA, USA) with a 10-kDa molec-
ular mass cut-o¡ membrane. Proteolytic processing of procathepsin D
was examined by incubating recombinant procathepsin D (2 Wg) with
the pepstatin A £ow-through fraction (5 Wg of protein) in 50 Wl of 20
mM sodium phosphate (pH 6.0) containing 50 mM NaCl. After in-
cubation for 1 h at room temperature, the reaction was stopped by
boiling for 5 min and analyzed by 10% SDS^PAGE.
2.4. Puri¢cation of a procathepsin D-processing enzyme
The pepstatin A £ow-through fraction was loaded into a Superdex
200 (HR 10/30) column (1U30 cm, Pharmacia LKB, Uppsala, Swe-
den) on a fast protein liquid chromatography (FPLC) system, which
was equilibrated with 0.05 M sodium phosphate bu¡er (pH 7.0), and
eluted with the same bu¡er at a £ow rate of 0.2 ml/min. All puri¢ca-
tion steps were carried out at 4‡C. Fractions (2 ml) were collected and
analyzed for procathepsin D-processing activity by 10% SDS^PAGE.
Active fractions were concentrated and desalted as above. The pooled
active fractions were injected into a Waters high pressure liquid chro-
matography (HPLC) system equipped with a gel permeation column
(8U300 mm, Shodex Protein KW-803, Showa Denko, Tokyo, Japan),
which was equilibrated with 0.05 M sodium phosphate bu¡er (pH
7.0), and were eluted with the same bu¡er at a £ow rate of 1 ml/
min. The puri¢ed enzyme with procathepsin D-processing activity was
subjected to the N-terminal sequence analysis by automatic Edman
degradation on an Applied Biosystems gas-phase sequencer, Model
477A (Foster City, CA, USA).
2.5. Characterization of the procathepsin D-processing enzyme
The pH optimum of the procathepsin D-processing enzyme was
determined using the same assay described above with the following
bu¡er systems: sodium citrate (20 mM, pH 4.0^5.0), sodium phos-
phate (20 mM, pH 6.0^8.0) and glycine^NaOH (20 mM, pH 9.0^
10.0). The e¡ects of protease inhibitors were examined by pre-incu-
bating the procathepsin D-processing enzyme for 1 h at room temper-
ature with each of the following protease inhibitors: PMSF (10 mM),
leupeptin (50 WM), E-64 (50 WM), pepstatin A (50 WM), EDTA (5 mM)
and o-phenanthroline (5 mM). Recombinant procathepsin D (2 Wg)
was then added in 50 Wl of the reaction bu¡er, and the protease
reactions were allowed to proceed for additional 1 h.
2.6. cDNA cloning of the gene encoding the procathepsin D-processing
enzyme
A cDNA encoding the procathepsin D-processing enzyme was iso-
lated from the cat¢sh skin cDNA library [14]. The library was
screened with a 32P-labeled 1721-nucleotide probe speci¢c to the pu-
ri¢ed protease, which was generated by 3P-RACE (3P-RACE PCR kit,
Life Technologies, Rockville, MD, USA). For the 3P-RACE, a PCR
primer (5P-GGNCCNAARCARGARGT-3P, where R=A, G; N=A,
C, G, T) was designed based on the amino acid sequence (residues
3^8) of the puri¢ed enzyme and used as a gene-speci¢c sense primer.
The nucleotide sequence of the selected clones was determined on
both strands using universal and sequence-speci¢c primers on an au-
tomated DNA sequencer (ABI prism model 377, Perkin Elmer, Foster
City, CA, USA).
2.7. Characterization of the processed cathepsin D
Recombinant procathepsin D (10 Wg) was incubated for 1 h at
room temperature with the puri¢ed procathepsin D-processing en-
zyme (3 Wg) in 100 Wl of 20 mM sodium phosphate (pH 7.0) contain-
ing 50 mM NaCl. The reaction mixture was then separated by 10%
SDS^PAGE and blotted onto a polyvinylene di£uoride membrane
(0.2 Wm pore size, Bio-Rad, Hercules, CA, USA) by semidry electro-
phoretic transfer. The band corresponding to the processed cathepsin
D was excised from the membrane for the N-terminal sequence anal-
ysis, which was performed on an Applied Biosystems gas-phase se-
quencer, Model 477A.
3. Results and discussion
3.1. Expression and puri¢cation of recombinant procathepsin D
The cDNA encoding a cat¢sh procathepsin D was PCR-
ampli¢ed and subcloned into pET-16b, which contained an
N-terminal tag composed of 10 histidine residues (His-tag)
for rapid puri¢cation and a factor Xa cleavage site for remov-
ing the N-terminal addition from the expressed protein. The
fusion protein was expressed as inclusion bodies in E. coli
BL21(DE3). After solubilization of the inclusion bodies, the
expressed protein was puri¢ed using Ni2þ a⁄nity column
chromatography. The fusion protein was then digested with
factor Xa to remove the N-terminal His-tag fusion peptide,
and reapplied to the Ni2þ a⁄nity column. The cleaved proca-
thepsin D was recovered to 98% homogeneity (data not
shown).
3.2. Puri¢cation and characterization of a procathepsin
D-processing enzyme
The mucus extracts were ¢rst applied to a pepstatin A-aga-
rose column to remove endogenous active cathepsin D by
binding to the column, and the pepstatin A £ow-through
fraction was puri¢ed by FPLC on a Superdex 200 column
(Fig. 1A and B). The active fractions with procathepsin
D-processing activity (81^90 min) were found to contain three
proteins, as con¢rmed by SDS^PAGE. Therefore, the active
fractions were further separated into a single protein band of
V60 kDa by HPLC on a Shodex gel permeation column (Fig.
1C and D). This puri¢ed enzyme was subjected to automated
Edman degradation for amino acid sequence analysis, which
allowed identi¢cation of the N-terminal 19 amino acid resi-
dues as VLGPKQEVPRAALEQTEAG.
The 60-kDa enzyme showed procathepsin D-processing ac-
tivity in the pH range of 5.0^8.0 and displayed optimal activ-
ity at pH 7.0 (Fig. 2). Table 1 shows the e¡ects of various
inhibitors on the activity of the 60-kDa enzyme. Metal-chelat-
ing agents such as EDTA and o-phenanthroline strongly in-
hibited the procathepsin D-processing activity whereas serine
protease inhibitors such as PMSF and leupeptin, a cysteine
protease inhibitor E-64, and an aspartic protease inhibitor
pepstatin A did not inhibit. These results clearly indicate
that the procathepsin D-processing enzyme induced in the
mucus of wounded cat¢sh was a metalloprotease. The size
of the processed cathepsin D is ca. 37 kDa which is the
same as that of native cathepsin D [14]. To determine the
cleavage speci¢city of the 60-kDa enzyme, we sequenced the
N-terminal amino acids of the processed cathepsin D. The
¢rst ¢ve amino acid residues were identi¢ed as GPTPE, which
exactly matched with those of mature cathepsin D. On the
basis of the above results, we concluded that the 60-kDa en-
zyme activated procathepsin D to mature cathepsin D by
cleaving the Phe61^Gly62 bond of procathepsin D.
3.3. cDNA cloning of the puri¢ed procathepsin D-processing
enzyme
A cDNA encoding the puri¢ed procathepsin D-processing
enzyme was obtained by screening the cat¢sh skin cDNA
library with a speci¢c probe generated by 3P-RACE. DNA
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sequence analysis of a 2052-bp cDNA showed an open read-
ing frame encoding a 638-residue polypeptide chain, which
consisted of a putative signal peptide of 18 amino acids, a
propeptide of 78 amino acids and a mature enzyme of 542
amino acids (GenBank accession number AF544370). A
search of the NCBI data bank through the BLAST network
service showed that the procathepsin D-processing enzyme
had a signi¢cant homology with matrix metalloproteinases
(MMPs), especially that of rainbow trout MMP 2 (Fig. 3).
The amino acid sequence of the puri¢ed enzyme showed 52%
identity with the rainbow trout MMP 2 [16], and contained all
the characteristics of MMPs such as a highly conserved metal
binding motif (HEXXHXXGXXH) in the catalytic domain
and a cysteine switch (PRCXXPD) in the propeptide [17].
The above results strongly suggest that the 60-kDa enzyme
puri¢ed is a cat¢sh homolog of MMP 2.
3.4. Conclusion
In this study, we found that MMP 2 is involved in the
enzymatic cascade reaction for the production of the antimi-
crobial peptide parasin I from histone H2A in cat¢sh skin
mucosa by acting as a procathepsin D-processing enzyme.
Using recombinant procathepsin D as a substrate, we assayed
the mucus extracts of wounded cat¢sh for procathepsin
D-processing activity and successfully puri¢ed a 60-kDa en-
zyme that is responsible for the conversion of 40-kDa proca-
Fig. 2. E¡ect of pH on the activity of the procathepsin D-process-
ing enzyme. Recombinant procathepsin D (2 Wg) was incubated
with the puri¢ed enzyme (1 Wg) in reaction bu¡ers in the pH range
of 4.0^10.0 (total reaction volume, 50 Wl). After incubation for 1 h
at room temperature, the reactions were stopped by boiling for
5 min and analyzed by 10% SDS^PAGE.
Fig. 1. Puri¢cation of a procathepsin D-processing enzyme from the mucus of wounded cat¢sh. A: Chromatography on an FPLC Superdex
200 column of the pepstatin A £ow-through fraction in which endogenous active cathepsin D was eliminated. B: Proteolytic cleavage of proca-
thepsin D by the fractions obtained from the Superdex 200 FPLC step. The procathepsin D-processing activity of each fraction (2 ml) was as-
sessed by incubating with recombinant procathepsin D (2 Wg, total reaction volume, 50 Wl). C: Gel permeation HPLC of the active fractions
(81^90 min) obtained from the Superdex 200 FPLC step on a Shodex Protein KW-803 column. D: SDS^PAGE analysis of the puri¢ed en-
zyme. An FPLC fraction containing the procathepsin D-processing activity (indicated by an arrow, a) was subjected to 10% SDS^PAGE.
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thepsin D to 37-kDa cathepsin D (Fig. 1). Amino acid se-
quence analysis and cDNA cloning identi¢ed the puri¢ed pro-
cathepsin D-processing enzyme as MMP 2 (Fig. 3). MMP 2
converts procathepsin D to cathepsin D by cleaving the
Phe61^Gly62 bond of procathepsin D, as con¢rmed by struc-
tural analysis of the processed protein.
In vertebrates, MMPs, including MMP 2, which are ex-
pressed or released in response to injury, disease or in£amma-
tion, are typically associated with the immune response and
tissue repair [18]. As their name suggests, MMPs are thought
to be responsible for the turnover and degradation of connec-
tive tissue proteins. However, matrix degradation is not the
sole function of these enzymes. Several reports have demon-
strated that various MMPs are involved in the activation of a
variety of non-matrix proteins, including cytokines, chemo-
kines, receptors and antimicrobial peptides [19]. Among
them, matrilysin (MMP 7), the expression of which is induced
by exposure to bacteria, has been reported to function in the
intestinal mucosal defense by regulating the activity of defen-
sins [20]. Our results suggest that the role of MMP 2 may be
extended to the innate host defense system beyond connective
tissue remodeling, speci¢cally being involved in the regulation
of parasin I production by acting as a procathepsin D con-
vertase.
Extracellular proteolytic processing of host defense peptides
from larger precursor polypeptides has been emerging as a
common theme in innate immunity. In bovine and porcine
neutrophils, antimicrobial peptides are liberated by elastase-
mediated cleavage of cathelicidins [21,22]. Recently, it has
been reported that the antimicrobial peptide buforin I is re-
leased from histone H2A by the action of pepsin in the gastric
mucosa of toad [13] and human K-defensin 5 (HD5) from
proHD5 by the action of trypsin in human Paneth cells [23].
The role played by pepsin in the processing of buforin I is
similar to that of cathepsin D in the production of parasin I.
But unlike pepsin which is autoactivated by hydrochloric acid,
cat¢sh cathepsin D is secreted to the mucosal surface as an
inactive proenzyme and activated to the mature enzyme by
MMP 2 induced upon epidermal injury. The enzymatic cas-
cade reaction involved in parasin I production is strikingly
similar to that of the prophenoloxidase (proPO)-activating
system in melanin formation of arthropods. In arthropods,
PO is synthesized as an inactive proenzyme, proPO, which
is activated by a proPO-activating enzyme (proPO-AE)
upon wounding or exposure to certain microbial polysaccha-
Fig. 3. Alignment of the amino acid sequence of vertebrate MMP 2. The multiple sequence alignment was obtained using the Clustal W pro-
gram with default parameters. The amino acid sequence of cat¢sh MMP 2 is aligned with those of MMP 2 from rainbow trout, medaka ¢sh,
mouse and human. Asterisks and colons indicate perfect matches of amino acids and conservative substitutions, respectively. Each domain is
assigned a signal peptide, a propeptide domain, a catalytic and a hemopexin-like domain. The cysteine switch motif (PRCXXPD) in the pro-
peptide domain is shown in bold. The metal binding motif (HEXXHXXGXXH) in the catalytic domain is boxed.
Table 1
E¡ects of protease inhibitors on the activity of the procathepsin
D-processing enzyme
Inhibitor Concentration Relative activity (%)a
None 100
Metalloprotease inhibitor
EDTA 5 mM 24
o-Phenanthroline 5 mM 11
Serine protease inhibitor
PMSF 10 mM 100
Leupeptin 50 WM 95
Cysteine protease inhibitor
E-64 50 WM 93
Aspartic protease inhibitor
Pepstatin A 50 WM 87
aRelative enzyme activities were calculated as the ratio of the
amount of processed procathepsin D in the presence of inhibitors to
that in the absence of inhibitor.
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rides. PO then catalyzes the oxidation of phenols to quinones,
which then polymerize non-enzymatically to melanin [24]. Be-
cause active PO can produce highly toxic intermediates, its
activation is tightly regulated by proPO-AE inhibitors such
as serpins [25]. The activation of cathepsin D might be regu-
lated similar to that of PO, although we did not con¢rm the
existence of cosecreted MMP 2 inhibitors in the cat¢sh mucus.
Further work will focus on the identi¢cation of MMP 2 in-
hibitors and their expression in vivo.
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